---
# ============================================
# MDX Paper Template - RSCT Certified Reviews
# ============================================

# Core Metadata
title: "Paper Title Here (Maximum 120 characters recommended)"
arxiv_id: "2402.12345"
authors: ["Last, First M.", "Last, First M.", "Last, First M."]
published_date: "2024-02-15"
go_live_date: "2026-03-01"

# RSCT Certification (Quality Gates)
kappa: 0.85                      # κ-gate score (0-1, recommend ≥0.7)
rsn_score: "0.75/0.82/0.43"      # R/S/N format string
R: 0.75                          # Relevance (0-1)
S: 0.82                          # Stability (0-1)
N: 0.43                          # Novelty (0-1)
# NOTE: R+S+N must equal 1.0 (simplex constraint)

# Classification
tags: ["multi-agent", "llm-reasoning", "control-theory"]
primary_topic: "multi-agent"
difficulty: "advanced"           # beginner | intermediate | advanced

# Content Metadata
abstract: |
  Short abstract summarizing the paper's main contribution.
  Keep to 2-3 sentences maximum. This appears in preview cards.

tldr: |
  • Key finding #1: Brief description
  • Key finding #2: Brief description
  • Key finding #3: Brief description

# Links
arxiv_url: "https://arxiv.org/abs/2402.12345"
pdf_url: "https://arxiv.org/pdf/2402.12345.pdf"
github_url: "https://github.com/author/repo"  # Optional

# Status
status: "staging"                # staging | live
featured: false                  # Show on homepage?

# Auto-calculated fields (do NOT manually set):
# reading_time: computed by Gatsby
# word_count: computed by Gatsby
---

## Summary

Provide a concise summary of the paper's main contributions. What problem does it solve? What approach does it take?

## Key Contributions

1. **First Contribution**: Detailed explanation of the first key contribution
2. **Second Contribution**: Detailed explanation of the second key contribution
3. **Third Contribution**: Detailed explanation of the third key contribution

## Methodology

Describe the paper's methodology:

- What techniques are used?
- How is the approach novel or different?
- What are the key innovations?

### Architecture

If applicable, describe the system architecture or model architecture.

```python
# Code examples can be included
def example_function():
    pass
```

## Results

Summarize the experimental results:

- What datasets were used?
- What metrics were reported?
- How does it compare to baselines?

| Metric | Baseline | This Paper | Improvement |
|--------|----------|------------|-------------|
| Accuracy | 85.2% | 92.1% | +6.9% |
| F1 Score | 0.83 | 0.91 | +0.08 |

## Implications

What are the implications of this work?

- **For Research**: How does this advance the field?
- **For Practice**: What are the practical applications?
- **For RSCT**: How does this relate to RSCT principles?

## Limitations

Acknowledge any limitations:

- Scope of evaluation
- Assumptions made
- Areas for future work

## RSCT Analysis

### Relevance (R = 0.75)

Explain why this paper is relevant to RSCT:

- Connection to multi-agent systems
- Relevance to quality gates / κ-gate scoring
- Application to simplex constraints (R+S+N=1)

### Stability (S = 0.82)

Discuss the stability and robustness of the approach:

- Reproducibility
- Generalization
- Theoretical foundations

### Novelty (N = 0.43)

Assess the novelty:

- What is genuinely new?
- What builds on existing work?
- Where are the innovations?

### κ-Gate Score (κ = 0.85)

Overall quality assessment:

- **Exceptional (κ ≥ 0.9)**: Gold tier - landmark paper
- **High Quality (κ ≥ 0.8)**: Silver tier - this paper qualifies
- **Certified (κ ≥ 0.7)**: Bronze tier - solid contribution
- **Pending (κ < 0.7)**: Below certification threshold

## References

List key references if needed:

1. AuthorLast, A., & AuthorLast, B. (2023). Related Work Title. *Conference/Journal*.
2. Another citation...

## Further Reading

Suggested papers for deeper understanding:

- [Related Paper 1](https://arxiv.org/abs/1234.56789)
- [Related Paper 2](https://arxiv.org/abs/9876.54321)

---

**Last Updated**: 2026-03-01
**Review Status**: Staging
**Next Review**: 2026-04-01
